Cardiac allograft vasculopathy (CAV) is a pathologic immune-mediated remodelling of the
vasculature in transplanted hearts and, by impairing perfusion, is the major cause of late …

Cochrane, Maria Crespo Leiro, Anne Dipchand, Brian Feingold, Kathleen Grady, Edward
Horn, Maryl Johnson, Donna Mancini, Sean Pinney, Heather Ross, Kari Wujcik, Andreas …

Heart transplantation is an accepted treatment for select patients with end-stage heart
failure. Improvements to immunosuppressive therapies and patient management have …

In the last decade, myocardial perfusion imaging (MPI) with PET has emerged to play a
pivotal role in the clinical routine process for the detection of hemodynamically significant …

Significant practice-changing developments have occurred in the care of heart
transplantation candidates and recipients over the past decade. This Canadian …

Microvascular dysfunction is responsible for chest pain in various kinds of patients, including
those with obstructive coronary artery disease and persistent symptoms despite …

Cardiac allograft vasculopathy remains a major limiting factor in the long-term survival of the
heart transplant recipient. Our understanding of its pathogenesis is continuously evolving as …

Abstract Purpose of Review Despite single-photon emission computerized tomography
(SPECT) being the most used nuclear imaging technique for diagnosis of coronary artery …

Ischemia with non-obstructive coronary arteries (INOCA) has gained increasing attention
due to its high prevalence, atypical clinical presentations, difficult diagnostic procedures …

Abstract Purpose of Review Infarction (MINOCA) and ischaemia (INOCA) with non-
obstructive coronary disease are recent non-conventional presentations of coronary …